Skip to main content
. 2021 Feb 10;16:27. doi: 10.1186/s11671-021-03475-5

Fig. 5.

Fig. 5

hucMSC-Exos attenuate pathological characteristics of PE rats. a Results of SBP in rats after exosome treatment. b Results of 24-h proteinuria in rats after exosome treatment. c Weight changes of fetal rats after exosome treatment. d Changes of placental weight in rats after exosome treatment. e Changes of inflammation factors after exosome treatment in serum were determined using ELISA. n = 10, *p < 0.05 versus the normal group. #p < 0.05 versus the PE group. $p < 0.05 versus the PE + Exos-antagomir NC group. Measurement data were depicted as mean ± standard deviation, and comparisons among multiple groups were assessed by one-way ANOVA followed by Tukey’s test